Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
about
Pleiotropic effects of pitavastatinPPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.Imaging of Intracellular and Extracellular ROS Levels in Atherosclerotic Mouse Aortas Ex Vivo: Effects of Lipid Lowering by Diet or AtorvastatinOxidized LDL and the metabolic syndromeEffects of rosuvastatin on the production and activation of matrix metalloproteinase-2 and migration of cultured rat vascular smooth muscle cells induced by homocysteine.An overview of the extra-lipid effects of rosuvastatin.The vicious circle between oxidative stress and inflammation in atherosclerosis.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice.In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin.Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.Genotoxicity evaluation of HMG CoA reductase inhibitor rosuvastatin.Rosuvastatin 1.2 mg In Situ Gel Combined With 1:1 Mixture of Autologous Platelet-Rich Fibrin and Porous Hydroxyapatite Bone Graft in Surgical Treatment of Mandibular Class II Furcation Defects: A Randomized Clinical Control Trial.HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
P2860
Q34633506-8CC846FE-F8E4-44C4-B6A7-61A2E576AC8EQ34689526-E6669D95-BA3B-4CC3-8343-04996A5789B8Q35670332-AE01CBD4-FBEE-4E48-BEA7-41F8B8A9E686Q37074685-C908FCB3-53BD-434F-8F2D-E3D551ADC4ACQ37076595-5F24B865-509A-40C4-BD20-6A1EF7DF1B7BQ37156139-EB1F0711-2E03-4296-AA92-C99CB07097BAQ37334949-351679F2-E4DC-43D2-8E50-2D229F9AE076Q38299279-76430B93-E721-4F97-8005-6290558FFB39Q43221638-0C6C88D2-6B9F-422F-A992-BC9DCE43E169Q46821545-17D8E47D-4A17-4198-B363-AB4FA1D26055Q47377607-3443C455-9329-42DF-A753-64173EE74731Q53082707-4E29F53A-4A86-4053-AAC4-51695CFA40B8Q53666033-31CBFC7E-8338-425D-A242-E7E09ED8AECEQ54440549-ED3D308C-6FFF-441A-9EFC-7D60517CA8E6
P2860
Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Rosuvastatin restores superoxi ...... ch of obese dyslipidemic mice.
@en
type
label
Rosuvastatin restores superoxi ...... ch of obese dyslipidemic mice.
@en
prefLabel
Rosuvastatin restores superoxi ...... ch of obese dyslipidemic mice.
@en
P2093
P2860
P356
P1476
Rosuvastatin restores superoxi ...... rch of obese dyslipidemic mice
@en
P2093
B Geeraert
D De Keyzer
F Desjardins
M-C Herregods
P2860
P304
P356
10.1038/SJ.BJP.0707231
P407
P577
2007-03-26T00:00:00Z